Register
Journal Updates
eMediNexus Coverage from: 
Study shows fewer relapses with fingolimod vs interferon beta-1a in pediatric multiple sclerosis
eMediNexus,  17 September 2018
remove_red_eye 658 Views
#Neurology #Pediatrics #Psychiatry

0 Read Comments                

Among pediatric patients with relapsing multiple sclerosis, fingolimod was associated with a lower rate of relapse and less accumulation of lesions on MRI over a 2-year period than interferon beta-1a but was associated with a higher rate of serious adverse events.
Read the full story.
Create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now